Energenesis Biomedical CO.,LTD. (TPE:6657)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.40
-0.85 (-2.81%)
Jul 30, 2026, 1:30 PM CST

TPE:6657 Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-207.74-258.4-231.08-260.38-265.66-120.24
Depreciation & Amortization
20.5522.5522.7623.7824.3522.85
Other Amortization
0.010.020.050.050.060.06
Loss (Gain) From Sale of Assets
0.030.01-0.22--
Stock-Based Compensation
15.8417.5614.8514.8711.094.92
Other Operating Activities
-0.38-0.63-0.72-1.04-0.010.46
Change in Accounts Receivable
-0.32-0.540.080.61-0.790.31
Change in Inventory
0.06-0.160.04-0.150.16-0.02
Change in Accounts Payable
-0.230.08-0.03-0.030.070.02
Change in Unearned Revenue
-2.66-2.68-0.93---0.04
Change in Other Net Operating Assets
-11.67-0.2214.28-2.97-2.12-5.6
Operating Cash Flow
-156.41-222.41-180.71-225.05-232.84-97.29
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2.67-2.31-0.75-0.84-6.45-8.9
Sale (Purchase) of Intangibles
-0.02-0.02---0.14-
Investment in Securities
345.4795.47192.11-58.11182-107
Other Investing Activities
0.04-1.321.87-00.13
Investing Cash Flow
342.8391.83193.23-58.96175.42-115.76

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--6.07-6.2-6.52-6.51-6.79
Net Debt Issued (Repaid)
-6.12-6.07-6.2-6.52-6.51-6.79
Issuance of Common Stock
1.94434.29151.49446.944.75294.65
Repurchase of Common Stock
-39.59-28.89----
Other Financing Activities
-----0.13
Financing Cash Flow
-43.77399.34145.29440.42-1.75287.98

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.13-0.160.09---
Net Cash Flow
142.52268.6157.9156.41-59.1874.94

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-159.08-224.72-181.47-225.89-239.29-106.18
Free Cash Flow Growth
------
Free Cash Flow Margin
-2025.96%-2928.30%-2341.79%-3155.81%-3255.16%-1417.84%
Free Cash Flow Per Share
-1.80-2.54-2.38-3.14-3.59-1.77
Levered Free Cash Flow
-122.3-131.5-110.26-129.83-148.4-57.24
Unlevered Free Cash Flow
-122-131.21-110.13-129.69-148.27-57.06

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.470.460.210.210.210.28
Cash Income Tax Paid
0.670.630.850.53-0.09-0.06
Change in Working Capital
15.27-3.5113.43-2.55-2.67-5.33